News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Shaibu Issa: Fighting for better hepatitis care globally
Shaibu Issa/LinkedIn
Dec 15, 2024, 08:17

Shaibu Issa: Fighting for better hepatitis care globally

Shaibu Issa, Member HBV Global Community Advisory Board at Hepatitis B Foundation, posted the following on LinkedIn:

“We will not stop until every person knows their status and gets the care they deserve.

Oohh God bless Us.”

cancer global health Global Liver Institute healthcare accessibility healthcare equity hepatitis awareness HEPATITIS B Hepatitis B Foundation James Viola Libiakova Liver health OncoDaily Oncology public health advocacy Sarah Manes Cary Shaibu Issa World Hepatitis Alliance
Special Coverage
Blog
Apr 5, 2025, 05:45
Aliasger Salem has received the 2025 Regents Award for Faculty Excellence
Blog
Apr 5, 2025, 05:36
Luca Arecco: Prognostic implications of risk definitions from the monarchE and NATALEE trials
Blog
Apr 5, 2025, 05:29
David J. Benjamin: Sexual health and reproductive toxicity from cancer therapies
Blog
Apr 5, 2025, 05:21
Cathy Eng: Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer
Blog
Apr 5, 2025, 05:18
Guillermo J. Ruiz-Argüelles: México was present in EBMT meeting in Florence
Opinion
Apr 5, 2025, 05:13
Abstract Submissions for the 22nd SIO International Conference are now open
Blog
Apr 5, 2025, 05:00
Welcoming Alastair Lamb to Barts Cancer Institute
Blog
Apr 5, 2025, 04:50
The Mark Foundation for Cancer Research's Scientific Symposium 2025
Blog
Apr 5, 2025, 02:56
Did you know ALK Positive can help you gain access to world-leading specialists - at no charge?
Blog
Apr 4, 2025, 20:41
Michael Sapienza: Colorectal Cancer Alliance is hiring a VP of Data Intelligence and Technology
Science
Apr 4, 2025, 20:29
Gaëlle Saint-Hilary: Benefit-risk assessment of ivosidenib vs. placebo in mIDH1 cholangiocarcinoma
Blog
Apr 4, 2025, 20:12
David Planchard: A pleasure to discuss diagnostic and therapeutic advances in EGFR lung patients in Cannes